INIS
patients
78%
diseases
72%
units
61%
covid-19
57%
coronaviruses
43%
anticoagulants
41%
monitoring
39%
mortality
34%
heparin
33%
levels
31%
reviews
22%
comparative evaluations
21%
matrices
17%
impedance
17%
applications
17%
validation
17%
membranes
17%
proteins
17%
biological markers
17%
pathogenesis
17%
animals
17%
plasticity
17%
pain
17%
thrombin
17%
tomography
17%
exploration
17%
compliance
17%
calibration
17%
tissues
16%
plasminogen
13%
Keyphrases
Intensive Care
78%
Coronavirus Disease (COVID)
78%
Maastricht
70%
COVID-19
66%
Rotational Thromboelastometry (ROTEM)
35%
Intensive Care Unit
29%
Unfractionated Heparin
28%
Non-survivors
27%
Anticoagulants
24%
Low Molecular Weight Heparin
23%
Anticoagulation
21%
Critically Ill COVID-19 Patients
20%
Coagulopathy
19%
Postoperative Pain
17%
COVID-19 Disease
17%
Critical COVID-19
17%
Heparin Monitoring
17%
Nociceptive Pathways
17%
Patient Observation
17%
Dephosphorylated Uncarboxylated Matrix Gla Protein
17%
Needle Prick
17%
Electrical Impedance Tomography
17%
Matrix Gla Protein
17%
Nociception
17%
Pulmonary Pathophysiology
17%
Later Life
17%
External Validation
17%
Thrombin Generation
17%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
17%
Alternative Anticoagulants
17%
Medicine and Dentistry
COVID-19
100%
Intensive Care
78%
Intensive Care Unit
49%
Thromboelastometry
35%
Anticoagulant
29%
Heparin
29%
Disease
25%
Pathophysiology
20%
Anticoagulation
20%
Coagulopathy
18%
Electrical Impedance Tomography
17%
Postoperative Pain
17%
Osteocalcin
17%
Thrombin
17%
Biological Marker
17%
Nociception
17%
Extracorporeal Membrane Oxygenation
17%
Low Molecular Weight Heparin
17%
Continuous Positive Airway Pressure
14%
Intubation
13%
Hind Paw
13%
Hypersensitivity
13%
Blood Clotting
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Tissue Plasminogen Activator
10%
Blood Stasis
10%
Antithrombotic
10%
Hypercoagulability
9%
Pulmonary Embolism
8%
Homeostasis
8%
